본문 바로가기 주메뉴 바로가기

Introduction

Introduction

Company Introduction

TMD Lab is an R&D-oriented
company with original technology related to shape memory polymers.

We have established a medical device pipeline with excellent controllability and a wide spectrum of physical properties and expandedour business to multi-D printing, textile chemistry industry, and material parts industries. As such, we are presenting new solutions in various industries.

The founder, Professor Hak-joon Sung, first developed theoriginal material technologyfor the shapememory polymer based on polycaprolactone while working for Vanderbilt University in the United States.

After joining asa professor at Yonsei University in Korea in 2018, Professor Hak-joon Sung further developed the source material technology of the shape memory polymer and started research on convergence medicinesand the development of the technology for medical devices that can be inserted into the body.

Since its foundation, TMD Lab has continued to develop the source material technologyfor five generations of the shape memory polymer by utilizing not only polycaprolactone but also various biocompatible polymers.

Currently, mass synthesis is enabled, and various production process techniques such as Multi-D printing, molding, and injection have been developed using the mass synthesis technology, and we are expanding the pipeline into various industries.

CEO’s Introduction

WELCOME TO TMD LAB

We strive to globalize the original technology of K-Medical materials.

Received the top 3 U.S. Scientist Award and Korea Pfizer Medical Award.
Published more than 20 papers in sister journals of Nature Science in the last 3 years.
Received more than 20 billion won for research projects.

Career History
  • - Currently, Head Professor at Yonsei University Medical School
  • - Doctor of Engineering, Georgia Tech & Emory University, USA
  • - Adjunct Professor at the Department of Mechanical Engineering, Georgia Tech, USA
  • - Adjunct Professor at the Biotechnology Research Centerof Pohang University of Science and Technology
  • - Chairman of the Medical Engineering Subcommittee in Vascular Research Group of the KoreanSociety of Cardiology
  • - Expert in technology level evaluation in the life, health and medical fields of the Ministry of Science and ICT
  • - Chairman of the Advanced Regenerative Medicine and Advanced Biopharmaceuticals Review Committee Convergence Treatment Specialist Committeeunder the Ministry of Health and Welfare
  • - Former Professor at Vanderbilt University
  • - Publication of 165 SCI(E) papers
  • - Registration of 5 US patents, 5 PCTs, and1 EP
  • - Registration of 2 domestic patents and application of 17 domestic patents
  • - 7 technology transfers

History

Pioneering new paths in advanced shape-memory polymer materials since our establishment in 2018

2018–2020

Foundation & Setup Phase

  • Incorporation & Investment Secured
  • Development of Shape-Memory Polymer Technology Completed
  • Selected for TIPA "Startup Growth Project (Strategic Project)" (KRW 400M R&D Funding)
  • Venture Business Certification & Manufacturing Permit Acquired
  • Secured Series A Investment in 2020
    (KRW 5.77B)
  • R&D Center Certification Obtained
    (Korea Industrial Technology Association)
  • Established Cleanroom Facility for Medical Device Production
2021–2023

Take off Phase

  • Selected for TIPA "Startup Growth Project (4IR)" (KRW 400M R&D Funding)
  • Selected for KMDF "Full-Cycle Medical Device R&D Project" (KRW 2.45B R&D Funding)
  • Obtained Medical Device GMP Certification
    (No. 6742)
  • Obtained Technology-Innovative (INNO-BIZ) Certification (No. 210105-01855)
  • Secured Series B Investment in 2021–2022
    (KRW 10B)
  • Additional Selection for TIPA "Startup Growth Project (Strategic Project)"
    (KRW 300M R&D Funding)
  • Selected for MOHW "Health & Medical Technology R&D Project"
    (KRW 1.2B R&D Funding)
  • MFDS Approval for Lacrimal Duct Stent (INNOSELF™-L) (No. 22-711)
  • Selected for MSIT "STEAM R&D Project"
    (KRW 4.3B R&D Funding)
2024–Present

Growth Phase

  • Signed Development Contract for Biocompatible Biopolymers (ZYMP, China)
  • Completed Development of Biocompatible Biopolymers (PGLA, PGA, PCL)
  • Obtained Medical Device Approval for Biliary Stent (No.25-3, Export Purpose Only)
  • Developed 3DP Resin for Clear Dental Aligners
    (P-INNOSELF™)
  • Clinical Trial Plan Approval (IND) for Veterinary Medical Device – Biliary Stent (INNOSELF™-B-A)
  • Acquired USP <88> Class Ⅵ Plastic Certification
  • Completed Development of Shape-Memory Wound Healing Patch
  • Successful Clinical Trial for Lacrimal Duct Stent (INNOSELF™-L)
  • 2026.06 Joint research agreement with Oh my teeth Inc. (Japan) on next-generation shape-memory materials for orthodontic aligners
  • Design, development, manufacturing, and sales of polymer products (ISO 9001:2015 Certified)

Vision

Business Model

Collaboration Progress Stages

R&D cooperation stage

  1. 01

    Identifying customer needs

  2. 02

    Proposal of the application method and discussion on the verific ation method

  3. 03

    1st verification

  4. 04

    Signing MOU

  5. 05

    Consultation on R&D contract conditions

  6. 06

    Conclusion and execution of the contract

Material/product provision stage

  1. 01

    Introduction of products/materials

  2. 02

    Market research and provision of sample (1st verification)

  3. 03

    Signing MOU

  4. 04

    Market evaluation

  5. 05

    Negotiation of supply contract conditions

  6. 06

    Conclusion and execution of the contract